314 related articles for article (PubMed ID: 16631255)
1. Late-onset retinoblastoma in a well-functioning fellow eye.
de Jong PT; Mooy CM; Stoter G; Eijkenboom WM; Luyten GP
Ophthalmology; 2006 Jun; 113(6):1040-4. PubMed ID: 16631255
[TBL] [Abstract][Full Text] [Related]
2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
3. Diffuse anterior retinoblastoma without retinal involvement.
Longmuir SQ; Syed NA; Boldt HC
Ophthalmology; 2010 Oct; 117(10):2034-8. PubMed ID: 20663567
[TBL] [Abstract][Full Text] [Related]
4. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
[TBL] [Abstract][Full Text] [Related]
5. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
6. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
Abramson DH; Schefler AC
Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
[TBL] [Abstract][Full Text] [Related]
7. Late recurrence of tumor necessitating enucleation in an adult onset retinoblastoma.
Khetan V; Mathur G; Kumar SK; Gopal L
Ophthalmic Genet; 2013; 34(1-2):87-9. PubMed ID: 22950453
[TBL] [Abstract][Full Text] [Related]
8. Intraocular surgery after treatment of germline retinoblastoma.
Moshfeghi DM; Wilson MW; Grizzard S; Haik BG
Arch Ophthalmol; 2005 Jul; 123(7):1008-12. PubMed ID: 16009848
[No Abstract] [Full Text] [Related]
9. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
10. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
11. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
12. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
[TBL] [Abstract][Full Text] [Related]
13. Chiasmatic infiltration secondary to late malignant transformation of retinoma.
Mataftsi A; Zografos L; Balmer A; Uffer S; Stupp R; Janzer RC; Pica A; Schorderet DF; Munier FL
Ophthalmic Genet; 2012 Sep; 33(3):155-8. PubMed ID: 21526971
[TBL] [Abstract][Full Text] [Related]
14. [Retinoblastoma update--therapy (Part II)].
Pogrzebielski A; Shields CL; Romanowska-Dixon B; Shields JA
Klin Oczna; 2006; 108(4-6):258-62. PubMed ID: 17020008
[TBL] [Abstract][Full Text] [Related]
15. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
Wilson MW; Haik BG; Billups CA; Rodriguez-Galindo C
Ophthalmology; 2007 Nov; 114(11):2077-82. PubMed ID: 17628684
[TBL] [Abstract][Full Text] [Related]
16. Chemoreduction in the management of retinoblastoma.
Shields JA; Shields CL; Meadows AT
Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
[No Abstract] [Full Text] [Related]
17. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
[TBL] [Abstract][Full Text] [Related]
18. [Current therapeutic management in retinoblastoma with invasion of the optic nerve--a case report].
Gavriş M; Neamţu S; Gavriş S; Ghiţuică A
Oftalmologia; 1999; 46(1):69-71. PubMed ID: 10641091
[TBL] [Abstract][Full Text] [Related]
19. Clinical predictors of high risk histopathology in retinoblastoma.
Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
